Houlihan Lokey's analyst price target has been modestly revised downward, decreasing by $0.36 to $211.14. Analysts have slightly adjusted assumptions for fair value, discount rate, and profit margin projections.
What's in the News
- At its AGM held on September 17, 2025, Houlihan Lokey ratified the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending March 31, 2026. (Client Announcements)
- Nano Dimension Ltd. has engaged Houlihan Lokey and Guggenheim Partners as exclusive financial advisors to assist in exploring and evaluating a range of strategic alternatives designed to maximize shareholder value. (Client Announcements)
- Between April 1, 2025 and June 30, 2025, Houlihan Lokey did not repurchase any shares. As of June 30, 2025, the company has completed the repurchase of 811,166 shares for $102.5 million. This represents 1.17% of shares under the buyback announced in May 2022. (Buyback Tranche Update)
Valuation Changes
- The Fair Value Estimate has decreased slightly from $211.50 to $211.14 per share.
- The Discount Rate has declined modestly from 8.15% to 8.10%.
- The Revenue Growth Projection has increased marginally from 12.35% to 12.39%.
- The Net Profit Margin has risen from 18.61% to 18.92%.
- The Future P/E Ratio has decreased from 29.43x to 28.82x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
